DOJ Indicts Democratic Lawmaker for Corruption
Martin Matishak, The Fiscal Times
The Justice Department has indicted Rep. Chaka Fattah (D-PA) on almost 30 federal counts of political corruption.
The 11-term congressman and four associates were indicted on 29 federal charges, including bribery, money laundering, falsification of records, and multiple counts of bank and mail fraud, the department announced Wednesday.
Related: Billions in Unfinished Business as Congress Heads Out for Vacation
The charges against Fattah and his associates stem from his failed run for Philadelphia mayor in 2007.
Fattah and the others "embarked on a wide-ranging conspiracy involving bribery, concealment of unlawful campaign contributions and theft of charitable and federal funds to advance their own personal interests,” according to Assistant Attorney General Leslie R. Caldwell.
Justice alleges that Fattah borrowed $1 million from a wealthy donor during his mayoral bid and that he returned $400,000 in unused funds and developed a scheme to repay the remaining $600,000 by tapping charitable and federal grants through a local non-profit the Pennsylvania lawmaker created.
Federal officials also allege that the Fattah sough to repay supporters by offering federal grants and used funds from both his mayoral and congressional campaigns to pay down his son's student loan debts of around $23,000.
"Public corruption takes a particularly heavy toll on our democracy because it undermines people’s basic belief that our elected leaders are committed to serving the public interest, not to lining their own pockets,” she said in a statement.
House Minority Leader Nancy Pelosi (D-CA) said that Fattah has stepped down as the top Democrat on the House Appropriations Commerce, Justice, Science and Related Agencies subcommittee.
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
